27 results
424B3
CELU
Celularity Inc - Ordinary Shares
1 Jun 22
Prospectus supplement
4:06pm
committee and the audit committee charter.
Dean C. Kehler qualifies as an audit committee financial expert within the meaning of SEC regulations
424B3
inrrc2u bppv4wth
3 May 22
Prospectus supplement
4:06pm
POS AM
1y1bvu zh
1 Apr 22
Prospectus update (post-effective amendment)
9:15pm
424B3
8rrxx2hr4l75wa7
12 Aug 21
Prospectus supplement
4:21pm
S-4/A
EX-10.27
z268xrb
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
S-4/A
EX-10.26
j58xgltcer85tvhgpm
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
S-4/A
EX-10.9
wurnaw 6qme1
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
8-K
EX-2.1
0zu9gdp
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
425
EX-2.1
8jrxz49urtggabm
8 Jan 21
Business combination disclosure
7:02am
DEF 14A
z5r 805orbs
4 Dec 20
Definitive proxy
5:23pm